Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Cellectar Biosciences (CLRB) stocks in Canada
Learn how to easily invest in Cellectar Biosciences stocks.
Cellectar Biosciences is a biotechnology business based in the US. Cellectar Biosciences stocks (CLRB.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.27 – a decrease of 15.74% over the previous week. Cellectar Biosciences employs 11 staff and has a market cap (total outstanding stock value) of $42.7 million.
How to buy shares in Cellectar Biosciences
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CLRB – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Cellectar Biosciences?
- Has coronavirus impacted Cellectar Biosciences shares?
- Cellectar Biosciences shares summary
- Compare share dealing platforms
- Is Cellectar Biosciences stock a buy or sell?
- Cellectar Biosciences performance over time
- Cellectar Biosciences's financials
- How volatile are Cellectar Biosciences shares?
- Does Cellectar Biosciences pay a dividend?
- Have Cellectar Biosciences shares ever split?
- Other common questions
Cellectar Biosciences stock price (NASDAQ:CLRB)Use our graph to track the performance of CLRB stocks over time.
Cellectar Biosciences shares at a glance
|Latest market close||$0.59|
|52-week range||$0.58 - $2.98|
|50-day moving average||$0.74|
|200-day moving average||$1.06|
|Wall St. target price||$5.58|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.46|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Cellectar Biosciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Cellectar Biosciences price performance over time
|1 week (2022-01-14)||-15.74%|
|1 month (2021-12-21)||-11.97%|
|3 months (2021-10-21)||-35.89%|
|6 months (2021-07-21)||-47.81%|
|1 year (2021-01-21)||-69.60%|
|2 years (2020-01-21)||-77.91%|
|3 years (2019-01-18)||2.02|
|5 years (2017-01-20)||1.28|
Cellectar Biosciences financials
|Gross profit TTM||$0|
|Return on assets TTM||-43.91%|
|Return on equity TTM||-79.62%|
|Market capitalisation||$42.7 million|
TTM: trailing 12 months
Cellectar Biosciences share dividends
We're not expecting Cellectar Biosciences to pay a dividend over the next 12 months.
Have Cellectar Biosciences's shares ever split?
Cellectar Biosciences's shares were split on a 1:10 basis on 16 July 2018. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Cellectar Biosciences shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Cellectar Biosciences shares which in turn could have impacted Cellectar Biosciences's share price.
Cellectar Biosciences share price volatility
Over the last 12 months, Cellectar Biosciences's shares have ranged in value from as little as $0.5816 up to $2.98. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cellectar Biosciences's is 1.559. This would suggest that Cellectar Biosciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Cellectar Biosciences overview
Cellectar Biosciences, Inc. , a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131, which is in Phase II clinical study in patients with relapsed or refractory (R/R) Waldenstrom's macroglobulinemia (WM) and B-cell malignancies; and Phase IIB clinical study in r/r multiple myeloma (MM) patients, as well as Phase I study for various pediatric cancers, R/R head and neck cancers, and R/R MM. The company also develops CLR 1900, a PDC chemotherapeutic program that is in the preclinical stage to treat solid tumors. It has collaborative PDC programs with Avicenna Oncology GMBH to develop CLR 2000 Series; Orano Med to develop CLR 12120 Series; and IntoCell Inc. Cellectar Biosciences, Inc. was founded in 2002 and is headquartered in Florham Park, New Jersey.
Stocks similar to Cellectar Biosciences
Cellectar Biosciences in the news
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
Is CanFite Biopharma Ltd (CANF) Outperforming Other Medical Stocks This Year?
Zacks.com featured highlights include: RentACenter, U.S. Physical Therapy, Cellectar Biosciences, Toro and Zymeworks
Frequently asked questions
More guides on Finder
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.
The ChampCoin (TCC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy The ChampCoin, lists some exchanges where you can get it and provides daily price data on TCC.